当前位置:首页 - 行情中心 - 张江高科(600895) - 财务分析 - 利润表

张江高科

(600895)

  

流通市值:469.25亿  总市值:469.25亿
流通股本:15.49亿   总股本:15.49亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入1,682,512,627.121,225,364,558.33980,182,506.882,025,737,630.73
营业收入1,682,512,627.121,225,364,558.33980,182,506.882,025,737,630.73
二、营业总成本1,366,870,127.52984,254,710.12693,447,606.511,546,109,755.87
营业成本697,348,205.84488,959,104.97412,359,523.57849,930,161.06
税金及附加191,466,974.6161,162,433.74131,851,331.41100,383,733.07
销售费用27,269,179.9815,906,628.289,088,860.3823,272,113.48
管理费用60,807,301.1443,007,119.9920,079,471.83115,935,606.55
财务费用389,978,465.96275,219,423.14120,068,419.32456,588,141.71
其中:利息费用438,893,661.06312,566,980.64145,510,273.38515,352,708.89
其中:利息收入54,627,811.535,969,812.6625,393,412.4857,181,310.08
加:公允价值变动收益256,616,449.34178,470,830.33-36,778,820.79645,235,136.18
加:投资收益70,620,749.65-103,813,945.91-100,769,686.71205,936,080.92
资产减值损失(新)----3,443,322.72
信用减值损失(新)-7,129,934.25-2,118,349.3-939,699.1-1,000,571.97
其他收益9,535,962.516,082,432.182,704,166.1421,147,745.4
营业利润平衡项目0000
四、营业利润645,285,726.85319,730,815.51150,950,859.911,347,502,942.67
加:营业外收入6,746.216,647.046,646.57693,538.76
减:营业外支出453,978.04453,880.47166.0136,340,407.01
利润总额平衡项目0000
五、利润总额644,838,495.02319,283,582.08150,957,340.471,311,856,074.42
减:所得税费用142,599,511.6169,371,131.4831,498,614.66371,210,396.75
六、净利润502,238,983.41249,912,450.6119,458,725.81940,645,677.67
持续经营净利润502,238,983.41249,912,450.6119,458,725.81940,645,677.67
归属于母公司股东的净利润511,019,707.53266,270,326.71119,033,432.68947,899,545.53
少数股东损益-8,780,724.12-16,357,876.11425,293.13-7,253,867.86
(一)基本每股收益0.330.170.080.61
(二)稀释每股收益0.330.170.080.61
八、其他综合收益-9,646,580.2414,497,914.083,840,331.3525,329,948.65
归属于母公司股东的其他综合收益-9,646,580.2414,497,914.083,840,331.3525,329,948.65
九、综合收益总额492,592,403.17264,410,364.68123,299,057.16965,975,626.32
归属于母公司股东的综合收益总额501,373,127.29280,768,240.79122,873,764.03973,229,494.18
归属于少数股东的综合收益总额-8,780,724.12-16,357,876.11425,293.13-7,253,867.86
公告日期2024-10-302024-08-242024-04-302024-03-30
审计意见(境内)标准无保留意见
TOP↑